Outcomes following extracorporeal membrane oxygenation in children with cardiac disease

Kate L Brown1, Rebecca Ichord, Bradley S Marino

  • 1Cardiac Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and Institute for Cardiovascular Science University College London, London, United Kingdom. Katherine.Brown@gosh.nhs.uk

Insights

Extracorporeal membrane oxygenation (ECMO) supports children with heart failure, with a 40% survival rate to discharge. Understanding ECMO outcomes is crucial for guiding its use in pediatric cardiac care.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a vital mechanical circulatory support for pediatric patients with severe heart disease and failure.
  • It is employed when conventional therapies fail, including during cardiac arrest unresponsive to resuscitation.

Purpose of the Study:

  • To review current knowledge on short- and long-term outcomes of ECMO in children with cardiac disease.
  • To inform the appropriate use and future development of ECMO in pediatric cardiac critical care.

Main Methods:

  • Systematic review of existing literature on ECMO outcomes in pediatric cardiac patients.
  • Analysis of survival rates, complications, and functional/neurologic outcomes.

Main Results:

  • Survival to hospital discharge for pediatric cardiac patients on ECMO is approximately 40%.
  • Outcomes vary significantly based on patient age, indication for support, and underlying cardiac condition.
  • ECMO, while lifesaving, is associated with significant complications and high costs.

Conclusions:

  • A comprehensive understanding of ECMO's short- and long-term results is essential for optimizing its application in pediatric cardiac care.
  • Further research and standardized guidelines are needed to improve patient outcomes and resource utilization.